Abstract
Background
Previous studies have demonstrated a disparity in liver transplantation (LT) for hepatocellular carcinoma (HCC) among races in the United States (U.S.).
Aims
We aimed to update the literature on the odds, trends, and complications of LT in the treatment of hepatocellular carcinoma (HCC), among individuals of different racial backgrounds.
Methods
This is a nationwide study of adult individuals admitted for LT with a primary diagnosis of HCC. Using weighted data from the National Inpatient Sample (NIS) database, we compared the odds of LT among different races from 2016 to 2020, using a multivariate regression analysis. We further assessed the trends and outcomes of LT among races.
Results
A total of 112,110 adult were hospitalized with a primary diagnosis of HCC. 3020 underwent LT. When compared to Whites, the likelihood of undergoing LT for HCC was significantly reduced in Blacks (OR = 0.60, 95% CI = 0.46–0.78). Further, Blacks had increased mortality rates (7% in Blacks vs. 1% in Whites, p < 0.001), sepsis (11% in Blacks vs. 3% in Whites, p = 0.015), and acute kidney injury (AKI) (54% in Blacks vs. 31% in Whites, p < 0.001) following LT.
Conclusions
Individuals identifying as Blacks were less likely to undergo LT for HCC, and more likely to develop complications. Further initiatives are warranted to mitigate the existing disparities among racial groups.
Graphical Abstract
Similar content being viewed by others
Change history
13 October 2023
A Correction to this paper has been published: https://doi.org/10.1007/s10620-023-08131-9
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394–424.
El-Serag HB, Kanwal F. Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go? Hepatology 2014;60:1767–1775.
EASL Clinical Practice Guidelines. Management of hepatocellular carcinoma. J Hepatol 2018;69:182–236.
Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet 2018;391:1301–1314.
Hartke J, Johnson M, Ghabril M. The diagnosis and treatment of hepatocellular carcinoma. Semin Diagn Pathol 2017;15:34153–34159.
Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, Roberts LR, Heimbach JK. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 2018;68:723–750.
Yau T, Tang VY, Yao TJ, Fan ST, Lo CM, Poon RT. Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma. Gastroenterology 2014;146:1691-1700.e1693.
Mehta N, Bhangui P, Yao FY et al. Liver transplantation for hepatocellular carcinoma: working group report from the ILTS transplant oncology consensus conference. Transplantation 2020;104:1136–1142.
Yu JC, Neugut AI, Wang S, Jacobson JS, Ferrante L, Khungar V, Lim E, Hershman DL, Brown RS Jr, Siegel AB. Racial and insurance disparities in the receipt of transplant among patients with hepatocellular carcinoma. Cancer 2010;116:1801–1809.
Corey KE, Pratt DS. Current status of therapy for hepatocellular carcinoma. Therap Adv Gastroenterol 2009;2:45–57.
Mehta N. Liver Transplantation Criteria for Hepatocellular Carcinoma Including Posttransplant Management. Clin Liver Dis (Hoboken) 2021;17:332–336.
Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693–699.
Organ Procurement and Transplantation Network (OPTN) Policies. Available from: https://optn.transplant.hrsa.gov/media/eavh5bf3/optn_policies.pdf. Accessed 10 June 2023
Rich NE, Hester C, Odewole M, Murphy CC, Parikh ND, Marrero JA, Yopp AC, Singal AG. Racial and ethnic differences in presentation and outcomes of hepatocellular carcinoma. Clin Gastroenterol Hepatol 2019;17:551-559.e551.
White DL, Thrift AP, Kanwal F, Davila J, El-Serag HB. Incidence of hepatocellular carcinoma in All 50 United States, from 2000 through 2012. Gastroenterology 2017;152:812-820.e815.
Ha J, Yan M, Aguilar M, Tana M, Liu B, Frenette CT, Bhuket T, Wong RJ. Race/ethnicity-specific disparities in hepatocellular carcinoma stage at diagnosis and its impact on receipt of curative therapies. J Clin Gastroenterol 2016;50:423–430.
Stewart SL, Kwong SL, Bowlus CL, Nguyen TT, Maxwell AE, Bastani R, Chak EW, Chen MS Jr. Racial/ethnic disparities in hepatocellular carcinoma treatment and survival in California, 1988–2012. World J Gastroenterol 2016;22:8584–8595.
Wong RJ, Devaki P, Nguyen L, Cheung R, Nguyen MH. Ethnic disparities and liver transplantation rates in hepatocellular carcinoma patients in the recent era: results from the Surveillance, Epidemiology, and End Results registry. Liver Transpl 2014;20:528–535.
Stepanova M, Wai H, Saab S, Mishra A, Venkatesan C, Younossi ZM. The outcomes of adult liver transplants in the United States from 1987 to 2013. Liver Int 2015;35:2036–2041.
Healthcare Cost and Utilization Project (HCUP). 2018 Introduction to the NIS. [Internet].Rockville (MD): Agency for Healthcare Research and Quality; Available from: www.hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2018.jsp
Houchens R, Ross D, Elixhauser A, Jiang J. Nationwide Inpatient Sample (NIS) Redesign Final Report Methods Series Report # 2 [Internet]. Rockville (MD): U.S Agency for Healthcare Research and Quality; 2014 Apr [cited 2023 Apr 25]. (HCUP Methods Series Report # 2014-04). Available from: https://www.hcup-us.ahrq.gov/reports/methods/methods.jsp
Khera R, Angraal S, Couch T, Welsh JW, Nallamothu BK, Girotra S, Chan PS, Krumholz HM. Adherence to methodological standards in research using the national inpatient sample. Jama 2017;318:2011–2018.
Healthcare Cost and Utilization Project. Trend Weights for HCUP NIS Data [April 24, 2023]. Available from: https://hcup-us.ahrq.gov/db/nation/nis/trendwghts.jsp. Accessed 24 April 2023
Hirode G, Saab S, Wong RJ. Trends in the Burden of chronic liver disease among hospitalized US adults. JAMA Netw Open 2020;3:e201997.
Simard M, Sirois C, Candas B. Validation of the combined comorbidity index of charlson and elixhauser to predict 30-day mortality across ICD-9 and ICD-10. Med Care 2018;56:441–447.
Farwati M, Amin M, Isogai T, Saad AM, Abushouk AI, Krishnaswamy A, Wazni O, Kapadia SR. Short-term outcomes following left atrial appendage closure in the very elderly: a population-based analysis. J Am Heart Assoc 2022;11:e024574.
Osman M, Khan MZ, Farjo PD, Khan MU, Khan SU, Benjamin MM, Munir MB, Balla S. In-hospital outcomes of percutaneous mitral valve repair in patients with chronic obstructive pulmonary disease: insights from the national inpatient sample database. Catheter Cardiovasc Interv 2021;97:E104-e112.
Ullah W, Gul S, Saleem S, Syed MA, Khan MZ, Zahid S, Minhas AMK, Virani SS, Mamas MA, Fischman DL. Trend, predictors, and outcomes of combined mitral valve replacement and coronary artery bypass graft in patients with concomitant mitral valve and coronary artery disease: a National Inpatient Sample database analysis. Eur Heart J Open 2022;2:002.
United Network for Organ Sharing. Transplant Trends [Internet]. UNOS; 2021. Available from: https://unos.org/data/transplant-trends/. Accessed 12 June 2023
Colmenero J, Rodríguez-Perálvarez M, Salcedo M et al. Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients. J Hepatol 2021;74:148–155.
Dakhoul L, Gawrieh S, Jones KR, Ghabril M, McShane C, Orman E, Vilar-Gomez E, Chalasani N, Nephew L. Racial disparities in liver transplantation for hepatocellular carcinoma are not explained by differences in comorbidities, liver disease severity, or tumor burden. Hepatol Commun 2019;3:52–62.
Nguyen GC, Segev DL, Thuluvath PJ. Racial disparities in the management of hospitalized patients with cirrhosis and complications of portal hypertension: a national study. Hepatology 2007;45:1282–1289.
Kemmer N, Zacharias V, Kaiser TE, Neff GW. Access to liver transplantation in the MELD era: role of ethnicity and insurance. Dig Dis Sci 2009;54:1794–1797.
Frenette CT. Increasing awareness on racial disparities in liver transplantation for hepatocellular carcinoma in the United States. Hepatol Commun 2019;3:5–7.
Chayanupatkul M, Omino R, Mittal S, Kramer JR, Richardson P, Thrift AP, El-Serag HB, Kanwal F. Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection. J Hepatol 2017;66:355–362.
Dillon ST, Bhasin MK, Feng X, Koh DW, Daoud SS. Quantitative proteomic analysis in HCV-induced HCC reveals sets of proteins with potential significance for racial disparity. J Transl Med 2013;11:239.
World Health Organization. Combating Hepatitis B And C To Reach Elimination By 2030 [Internet]. WHO; 2021. Available from: https://www.who.int/publications/i/item/combating-hepatitis-b-and-c-to-reach-elimination-by-2030. Accessed 07 July 2023
Kanwal F, Kramer J, Asch SM, Chayanupatkul M, Cao Y, El-Serag HB. Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents. Gastroenterology 2017;153:996–1005.
Nguyen GC, Thuluvath PJ. Racial disparity in liver disease: Biological, cultural, or socioeconomic factors. Hepatology 2008;47:1058–1066.
Kwong AJ, Ebel NH, Kim WR, Lake JR, Smith JM, Schladt DP, Skeans MA, Foutz J, Gauntt K, Cafarella M, Snyder JJ, Israni AK. OPTN/SRTR 2020 Annual Data Report: Liver. Am J Transpl 2020;2:204–309.
Eckhoff DE, McGuire BM, Young CJ, Sellers MT, Frenette LR, Hudson SL, Contreras JL, Bynon S. Race: a critical factor in organ donation, patient referral and selection, and orthotopic liver transplantation? Liver Transpl Surg 1998;4:499–505.
Strauss AT, Sidoti CN, Purnell TS et al. Multicenter study of racial and ethnic inequities in liver transplantation evaluation: Understanding mechanisms and identifying solutions. Liver Transpl 2022;28:1841–1856.
US Census Bureau. 2020 Census: Racial and Ethnic Diversity Index by State. https://www.census.gov/library/visualizations/2021/dec/racial-and-ethnic-diversity-index.html. Accessed 12 June 2023
Quillin RC 3rd, Wilson GC, Wima K et al. Independent effect of black recipient race on short-term outcomes after liver transplantation. Surgery 2015;157:774–784.
Funding
There was no explicit support or funding for this research.
Author information
Authors and Affiliations
Contributions
YK: Conceptualization; Methodology; Formal analysis and investigation; Writing—Original draft preparation; Writing—review, and editing. SAFK: Writing—Original draft preparation and Writing—Original draft preparation. FV: Original draft preparation and Writing—Original draft preparation. SV: Original draft preparation and Writing—Original draft preparation. MA: Writing—review, and editing. SA: Writing—review, and editing. YA: Writing – review, and editing. HS: Writing—review, and editing. VK Writing—review, and editing. LN, MD: Writing—review, and editing. AKK, MD: Conceptualization, Formal analysis and investigation, Writing—review, and editing, Supervision.
Corresponding author
Ethics declarations
Competing interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original online version of this article was revised: The mistakes in Discussion and Conclusion sections have been corrected.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Kilani, Y., Kamal, S.A.F., Vikash, F. et al. Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma in the United States: An Update. Dig Dis Sci 68, 4050–4059 (2023). https://doi.org/10.1007/s10620-023-08084-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-023-08084-z